Patents by Inventor Adam SILVERMAN

Adam SILVERMAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210049887
    Abstract: Fall detection and reporting technology, in which output from at least one sensor configured to sense, in a room of a building, activity associated with a patient falling is monitored and a determination is made to capture one or more images of the room based on the monitoring. An image of the room is captured with a camera positioned to include the patient within a field of view of the camera and the captured image of the room is analyzed to detect a state of the patient at a time of capturing the image. A potential fall event for the patient is determined based on the detected state of the patient and a message indicating the potential fall event for the patient is sent based on the determination of the potential fall event for the patient. Techniques are also described for fall detection and reporting using an on-body sensing device.
    Type: Application
    Filed: October 30, 2020
    Publication date: February 18, 2021
    Inventors: Mark Andrew Hanson, Jean-Paul Martin, Adam T. Barth, Christopher Silverman
  • Publication number: 20210020022
    Abstract: Methods, systems, and apparatus, including computer programs encoded on a storage device, are disclosed. A system includes one or more processors and one or more computer storage media storing instructions that are operable, when executed by the one or more processors, to cause the one or more processors to perform operations comprising: obtaining, by the system, video of a scene captured by a camera; determining a likelihood that the camera will be tampered with based on the video of the scene; determining that the likelihood that the camera will be tampered with satisfies criteria; and transmitting data generated from the video.
    Type: Application
    Filed: July 14, 2020
    Publication date: January 21, 2021
    Inventors: David James Hutz, Allison Beach, Weihong Yin, Donald Gerard Madden, Adam Gordon, Benjamin Asher Berg, Christopher Silverman, Donald Faraci
  • Publication number: 20200358652
    Abstract: According to certain embodiments, a provisioning manager comprises an interface and processing circuitry. The interface is configured to obtain provisioning data from a provisioning database. The processing circuitry is configured to prepare one or more configuration files based on the provisioning data and provide the one or more configuration files to the one or more service instances using file distribution technology. The one or more configuration files indicate how to provision one or more service instances used in sending or receiving electronic messages.
    Type: Application
    Filed: July 29, 2020
    Publication date: November 12, 2020
    Inventors: Bryan Adam Joyner, Kelly Sue Morrison, Dustin Stewart Silverman, Patrick Stephen Trantham
  • Patent number: 10825315
    Abstract: Fall detection and reporting technology, in which output from at least one sensor configured to sense, in a room of a building, activity associated with a patient falling is monitored and a determination is made to capture one or more images of the room based on the monitoring. An image of the room is captured with a camera positioned to include the patient within a field of view of the camera and the captured image of the room is analyzed to detect a state of the patient at a time of capturing the image. A potential fall event for the patient is determined based on the detected state of the patient and a message indicating the potential fall event for the patient is sent based on the determination of the potential fall event for the patient. Techniques are also described for fall detection and reporting using an on-body sensing device.
    Type: Grant
    Filed: July 30, 2018
    Date of Patent: November 3, 2020
    Assignee: Alarm.com Incorporated
    Inventors: Mark Andrew Hanson, Jean-Paul Martin, Adam T. Barth, Christopher Silverman
  • Publication number: 20200317749
    Abstract: The present disclosure relates to albumin variants, derivatives and analogs thereof. In particular, provided are albumin variants that bind with increased efficiency to FcRn, including albumin variants that bind with increased efficiency at low pH levels but inefficiently or not at all at neutral pH levels. The albumin variants, derivatives, and analogs have an increased serum half-life when compared to naturally-occurring albumins.
    Type: Application
    Filed: June 29, 2017
    Publication date: October 8, 2020
    Applicant: DENALI THERAPEUTICS INC.
    Inventors: Mark S. Dennis, Mihalis Kariolis, Adam Silverman
  • Patent number: 10679756
    Abstract: Health and wellness management technology, in which events that relate to activity within the monitored property are sensed based on output from sensors located at a monitored property. Behaviors are detected based on the sensed events that relate to activity within the monitored property and, in accordance with the detected behaviors, one or more models are created based on a likelihood of similarly expressed events happening at similar times with similar characteristics. Additional behaviors detected after creation of the one or more models are evaluated against the one or more models to determine whether the additional behaviors are consistent with the one or more models. At least one action is performed based on the determination of whether the additional behaviors are consistent with the one or more models.
    Type: Grant
    Filed: November 21, 2016
    Date of Patent: June 9, 2020
    Assignee: Alarm.com Incorporated
    Inventors: Mark Andrew Hanson, Christopher Silverman, Adam T. Barth
  • Publication number: 20190048051
    Abstract: Polypeptides comprising variant vascular endothelial growth factor sequences are provided. The polypeptides are useful in cancer imaging, cancer diagnosis, monitoring and treatment as well as treatment of diseases characterized by excessive neovascularization.
    Type: Application
    Filed: October 25, 2018
    Publication date: February 14, 2019
    Inventors: Jennifer R. Cochran, Adam Silverman, Douglas Jones, Niv Papo
  • Patent number: 9505822
    Abstract: Polypeptides comprising variant vascular endothelial growth factor sequences are provided. The polypeptides are useful in cancer imaging, cancer diagnosis, monitoring and treatment as well as treatment of diseases characterized by excessive neovascularization.
    Type: Grant
    Filed: October 9, 2014
    Date of Patent: November 29, 2016
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Jennifer R. Cochran, Adam Silverman, Douglas Jones, Niv Papo
  • Patent number: 9441026
    Abstract: Polypeptides comprising variant vascular endothelial growth factor sequences are provided. The polypeptides are useful in cancer imaging, cancer diagnosis, monitoring and treatment as well as treatment of diseases characterized by excessive neovascularization.
    Type: Grant
    Filed: October 9, 2014
    Date of Patent: September 13, 2016
    Assignee: The Board of Trustees of the Leland Standford Junior University
    Inventors: Jennifer R. Cochran, Adam Silverman, Douglas Jones, Niv Papo
  • Publication number: 20160039895
    Abstract: Polypeptides comprising variant vascular endothelial growth factor sequences are provided. The polypeptides are useful in cancer imaging, cancer diagnosis, monitoring and treatment as well as treatment of diseases characterized by excessive neovascularization.
    Type: Application
    Filed: August 17, 2015
    Publication date: February 11, 2016
    Inventors: Jennifer R. Cochran, Adam Silverman, Douglas Jones, Niv Papo
  • Publication number: 20160039896
    Abstract: Polypeptides comprising variant vascular endothelial growth factor sequences are provided. The polypeptides are useful in cancer imaging, cancer diagnosis, monitoring and treatment as well as treatment of diseases characterized by excessive neovascularization.
    Type: Application
    Filed: August 17, 2015
    Publication date: February 11, 2016
    Inventors: Jennifer R. Cochran, Adam Silverman, Douglas Jones, Niv Papo
  • Patent number: 9234021
    Abstract: Polypeptides comprising variant vascular endothelial growth factor sequences are provided. The polypeptides are useful in cancer imaging, cancer diagnosis, monitoring and treatment as well as treatment of diseases characterized by excessive neovascularization.
    Type: Grant
    Filed: April 21, 2014
    Date of Patent: January 12, 2016
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Jennifer R. Cochran, Adam Silverman, Douglas Jones, Niv Papo
  • Publication number: 20150037888
    Abstract: Polypeptides comprising variant vascular endothelial growth factor sequences are provided. The polypeptides are useful in cancer imaging, cancer diagnosis, monitoring and treatment as well as treatment of diseases characterized by excessive neovascularization.
    Type: Application
    Filed: October 9, 2014
    Publication date: February 5, 2015
    Inventors: Jennifer R. Cochran, Adam Silverman, Douglas Jones, Niv Papo
  • Publication number: 20150037889
    Abstract: Polypeptides comprising variant vascular endothelial growth factor sequences are provided. The polypeptides are useful in cancer imaging, cancer diagnosis, monitoring and treatment as well as treatment of diseases characterized by excessive neovascularization.
    Type: Application
    Filed: October 9, 2014
    Publication date: February 5, 2015
    Inventors: Jennifer R. Cochran, Adam Silverman, Douglas Jones, Niv Papo
  • Publication number: 20150005235
    Abstract: Polypeptides comprising variant vascular endothelial growth factor sequences are provided. The polypeptides are useful in cancer imaging, cancer diagnosis, monitoring and treatment as well as treatment of diseases characterized by excessive neovascularization.
    Type: Application
    Filed: September 3, 2014
    Publication date: January 1, 2015
    Inventors: Jennifer R. Cochran, Adam Silverman, Douglas Jones, Niv Papo
  • Publication number: 20140356286
    Abstract: Polypeptides comprising variant vascular endothelial growth factor sequences are provided. The polypeptides are useful in cancer imaging, cancer diagnosis, monitoring and treatment as well as treatment of diseases characterized by excessive neovascularization.
    Type: Application
    Filed: April 21, 2014
    Publication date: December 4, 2014
    Applicant: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Jennifer R. Cochran, Adam Silverman, Douglas Jones, Niv Papo
  • Patent number: 8741839
    Abstract: Polypeptides comprising variant vascular endothelial growth factor sequences are provided. The polypeptides are useful in cancer imaging, cancer diagnosis, monitoring and treatment as well as treatment of diseases characterized by excessive neovascularization.
    Type: Grant
    Filed: January 18, 2010
    Date of Patent: June 3, 2014
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Jennifer R. Cochran, Adam Silverman, Douglas Jones, Niv Papo
  • Publication number: 20120020889
    Abstract: Polypeptides comprising variant vascular endothelial growth factor sequences are provided. The polypeptides are useful in cancer imaging, cancer diagnosis, monitoring and treatment as well as treatment of diseases characterized by excessive neovascularization.
    Type: Application
    Filed: January 18, 2010
    Publication date: January 26, 2012
    Inventors: Jennifer R. Cochran, Adam Silverman, Douglas Jones, Niv Papo
  • Publication number: 20090257952
    Abstract: Engineered peptides that bind with high affinity (low equilibrium dissociation constant (Kd)) to the cell surface receptors of fibronectin (?5?1) or vitronectin (?v?3 and ?v?5 integrins) are disclosed. These peptides are based on a molecular scaffold into which a subsequence containing the RGD integrin-binding motif has been inserted. The subsequence (RGD mimic) comprises about 9-13 amino acids, and the RGD contained within the subsequence can be flanked by a variety of amino acids, the sequence of which was determined by sequential rounds of selection (in vitro evolution). The molecular scaffold is preferably based on a knottin, e.g., EETI (Trypsin inhibitor 2 (Trypsin inhibitor II) (EETI-II) [Ecballium elaterium (Jumping cucumber)], AgRP (Agouti-related protein), and Agatoxin IVB, which peptides have a rigidly defined three-dimensional conformation. It is demonstrated that EETI tolerates mutations in other loops and that the present peptides may be used as imaging agents.
    Type: Application
    Filed: April 3, 2009
    Publication date: October 15, 2009
    Applicant: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Jennifer R. COCHRAN, Richard KIMURA, Aron M. LEVIN, Adam SILVERMAN, Sanjiv S. GAMBHIR, Zhen CHENG, Jennifer LAHTI